Stefania Hroncekova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stefania Hroncekova has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jan Tkac
Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 9, 845 38 Bratislava, Slovak Republic
3 shared publications - Lenka Lorencova
Institute of Chemistry, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 38 Bratislava, Slovakia
3 shared publications - Peter Kasak
Center for Advanced Materials, Qatar University, Doha, Qatar
3 shared publications - Tomas Bertok
Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 9, 845 38 Bratislava, Slovak Republic
3 shared publications - Alica Vikartovská
Department of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 9, 845 38 Bratislava, Slovakia
2 shared publications - Eduard Jane
Institute of Chemistry, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 38 Bratislava, Slovakia
2 shared publications
Latest Publications
- Open Access
Spectrally Resolved Cell Imaging for Enhanced Production of ε-Caprolactone via an Enzyme Cascade Reaction in E. coli Immobilized Within Barium–Calcium Alginate Beads Using JetCutter
Jet-cutting—the most powerful immobilization technique—was utilized for the entrapment of recombinant E. coli cells expressing a cascade of enzymes, including alcohol dehydrogenase, enoate reductase, and cyclohexanone monooxygenase, within mechanically reinforced barium–calcium alginate beads. Cost-effective alginate beads with entrapped cells were applied in a model process for the production of the industrially relevant ε-caprolactone under bioreactor-controlled conditions, enabling parallel repeated biotransformations. Immobilization resulted in a reduced rate of cell deactivation over four biotransformation cycles, leading to overall ε-caprolactone yield increases of 36% using 0.55 mm beads and 22% using 0.9 mm beads compared to the use of free cells. Additionally, the model bioprocess was employed to investigate the metabolic adaptation of cells to immobilization and repeated biotransformations using viability assays and spectrally resolved confocal microscopy. These measurements, conducted for the first time throughout the entire cellular life cycle, clearly demonstrated that the cells retained high viability during cultivation, immobilization, and repeated use in biotransformations. Moreover, based on characteristic spectral shifts, advanced analysis via spectrally resolved confocal microscopy revealed distinct mechanisms of metabolic adaptation in entrapped cells versus free cells during repeated cascade reactions in parallel bioreactors.
Open AccessSpectrally Resolved Cell Imaging for Enhanced Production of ε-Caprolactone via an Enzyme Cascade Reaction in E. coli Immobilized Within Barium–Calcium Alginate Beads Using JetCutter
Jet-cutting—the most powerful immobilization technique—was utilized for the entrapment of recombinant E. coli cells expressing a cascade of enzymes, including alcohol dehydrogenase, enoate reductase, and cyclohexanone monooxygenase, within mechanically reinforced barium–calcium alginate beads. Cost-effective alginate beads with entrapped cells were applied in a model process for the production of the industrially relevant ε-caprolactone under bioreactor-controlled conditions, enabling parallel repeated biotransformations. Immobilization resulted in a reduced rate of cell deactivation over four biotransformation cycles, leading to overall ε-caprolactone yield increases of 36% using 0.55 mm beads and 22% using 0.9 mm beads compared to the use of free cells. Additionally, the model bioprocess was employed to investigate the metabolic adaptation of cells to immobilization and repeated biotransformations using viability assays and spectrally resolved confocal microscopy. These measurements, conducted for the first time throughout the entire cellular life cycle, clearly demonstrated that the cells retained high viability during cultivation, immobilization, and repeated use in biotransformations. Moreover, based on characteristic spectral shifts, advanced analysis via spectrally resolved confocal microscopy revealed distinct mechanisms of metabolic adaptation in entrapped cells versus free cells during repeated cascade reactions in parallel bioreactors.
- Open Access
- 17 March 2023
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 14 (3) , 161
Amperometric Miniaturised Portable Enzymatic Nanobiosensor for the Ultrasensitive Analysis of a Prostate Cancer Biomarker
Screen-printing technology is a game changer in many fields including electrochemical biosensing. Two-dimensional nanomaterial MXene Ti3C2Tx was integrated as a nanoplatform to immobilise enzyme sarcosine oxidase (SOx) onto the interface of screen-printed carbon electrodes (SPCEs). A miniaturised, portable, and cost-effective nanobiosensor was constructed using chitosan as a biocompatible glue for the ultrasensitive detection of prostate cancer biomarker sarcosine. The fabricated device was characterised with energy-dispersive X-ray spectroscopy (EDX), electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). Sarcosine was detected indirectly via the amperometric detection of H2O2 formed during enzymatic reaction. The nanobiosensor could detect sarcosine down to 7.0 nM with a maximal peak current output at 4.10 ± 0.35 × 10−5 A using only 100 µL of a sample per measurement. The assay run in 100 μL of an electrolyte showed the first linear calibration curve in a concentration window of up to 5 μM with a slope of 2.86 μA·μM−1, and the second linear calibration curve in the range of 5–50 μM with a slope of 0.32 ± 0.01 μA·μM−1 (R2 = 0.992). The device provided a high recovery index of 92.5% when measuring an analyte spiked into artificial urine, and could be used for detection of sarcosine in urine for at least a period of 5 weeks after the preparation.
- 17 March 2023
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 14 (3) , 161
Open AccessAmperometric Miniaturised Portable Enzymatic Nanobiosensor for the Ultrasensitive Analysis of a Prostate Cancer Biomarker
Screen-printing technology is a game changer in many fields including electrochemical biosensing. Two-dimensional nanomaterial MXene Ti3C2Tx was integrated as a nanoplatform to immobilise enzyme sarcosine oxidase (SOx) onto the interface of screen-printed carbon electrodes (SPCEs). A miniaturised, portable, and cost-effective nanobiosensor was constructed using chitosan as a biocompatible glue for the ultrasensitive detection of prostate cancer biomarker sarcosine. The fabricated device was characterised with energy-dispersive X-ray spectroscopy (EDX), electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). Sarcosine was detected indirectly via the amperometric detection of H2O2 formed during enzymatic reaction. The nanobiosensor could detect sarcosine down to 7.0 nM with a maximal peak current output at 4.10 ± 0.35 × 10−5 A using only 100 µL of a sample per measurement. The assay run in 100 μL of an electrolyte showed the first linear calibration curve in a concentration window of up to 5 μM with a slope of 2.86 μA·μM−1, and the second linear calibration curve in the range of 5–50 μM with a slope of 0.32 ± 0.01 μA·μM−1 (R2 = 0.992). The device provided a high recovery index of 92.5% when measuring an analyte spiked into artificial urine, and could be used for detection of sarcosine in urine for at least a period of 5 weeks after the preparation.
- Open Access
- 4 August 2021
- Published by MDPI AG in Chemosensors
- Vol. 9 (8) , 205
Novel Prostate Cancer Biomarkers: Aetiology, Clinical Performance and Sensing Applications
The review initially provides a short introduction to prostate cancer (PCa) incidence, mortality, and diagnostics. Next, the need for novel biomarkers for PCa diagnostics is briefly discussed. The core of the review provides details about PCa aetiology, alternative biomarkers available for PCa diagnostics besides prostate specific antigen and their biosensing. In particular, low molecular mass biomolecules (ions and metabolites) and high molecular mass biomolecules (proteins, RNA, DNA, glycoproteins, enzymes) are discussed, along with clinical performance parameters.
- 4 August 2021
- Published by MDPI AG in Chemosensors
- Vol. 9 (8) , 205
Open AccessNovel Prostate Cancer Biomarkers: Aetiology, Clinical Performance and Sensing Applications
The review initially provides a short introduction to prostate cancer (PCa) incidence, mortality, and diagnostics. Next, the need for novel biomarkers for PCa diagnostics is briefly discussed. The core of the review provides details about PCa aetiology, alternative biomarkers available for PCa diagnostics besides prostate specific antigen and their biosensing. In particular, low molecular mass biomolecules (ions and metabolites) and high molecular mass biomolecules (proteins, RNA, DNA, glycoproteins, enzymes) are discussed, along with clinical performance parameters.
- Open Access
Ultrasensitive Ti3C2TX MXene/Chitosan Nanocomposite-Based Amperometric Biosensor for Detection of Potential Prostate Cancer Marker in Urine Samples
Two-dimensional layered nanomaterial Ti3C2TX (a member of the MXene family) was used to immobilise enzyme sarcosine oxidase to fabricate a nanostructured biosensor. The device was applied for detection of sarcosine, a potential prostate cancer biomarker, in urine for the first time. The morphology and structures of MXene have been characterised by atomic force microscopy (AFM) and scanning electron microscopy (SEM). Electrochemical measurements, SEM and AFM analysis revealed that MXene interfaced with chitosan is an excellent support for enzyme immobilisation to fabricate a sensitive biosensor exhibiting a low detection limit of 18 nM and a linear range up to 7.8 µM. The proposed biosensing method also provides a short response time of 2 s and high recovery index of 102.6% for detection of sarcosine spiked into urine sample in a clinically relevant range.
Open AccessUltrasensitive Ti3C2TX MXene/Chitosan Nanocomposite-Based Amperometric Biosensor for Detection of Potential Prostate Cancer Marker in Urine Samples
Two-dimensional layered nanomaterial Ti3C2TX (a member of the MXene family) was used to immobilise enzyme sarcosine oxidase to fabricate a nanostructured biosensor. The device was applied for detection of sarcosine, a potential prostate cancer biomarker, in urine for the first time. The morphology and structures of MXene have been characterised by atomic force microscopy (AFM) and scanning electron microscopy (SEM). Electrochemical measurements, SEM and AFM analysis revealed that MXene interfaced with chitosan is an excellent support for enzyme immobilisation to fabricate a sensitive biosensor exhibiting a low detection limit of 18 nM and a linear range up to 7.8 µM. The proposed biosensing method also provides a short response time of 2 s and high recovery index of 102.6% for detection of sarcosine spiked into urine sample in a clinically relevant range.